Viemed Healthcare, Inc. VMD
We take great care to ensure that the data presented and summarized in this overview for VIEMED HEALTHCARE, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding VMD
View all-
Thrivent Financial For Lutherans Minneapolis, MN3.43MShares$29.5 Million0.05% of portfolio
-
Black Rock Inc. New York, NY2.91MShares$25.1 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.85MShares$15.9 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$15.6 Million0.0% of portfolio
-
Forager Capital Management, LLC Birmingham, AL1.72MShares$14.8 Million4.96% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.3MShares$11.2 Million3.78% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.14MShares$9.82 Million3.44% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.14MShares$9.78 Million0.49% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN796KShares$6.86 Million0.35% of portfolio
-
Geode Capital Management, LLC Boston, MA773KShares$6.66 Million0.0% of portfolio
Latest Institutional Activity in VMD
Top Purchases
Top Sells
About VMD
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Insider Transactions at VMD
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 26
2024
|
Nitin Kaushal Director |
SELL
Open market or private sale
|
Direct |
5,995
-4.51%
|
$47,960
$8.58 P/Share
|
Nov 26
2024
|
Nitin Kaushal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,995
+4.32%
|
$11,990
$2.5 P/Share
|
Nov 25
2024
|
Nitin Kaushal Director |
SELL
Open market or private sale
|
Direct |
24,005
-15.91%
|
$192,040
$8.7 P/Share
|
Nov 25
2024
|
Nitin Kaushal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,005
+13.73%
|
$48,010
$2.5 P/Share
|
Nov 20
2024
|
Nitin Kaushal Director |
SELL
Open market or private sale
|
Direct |
15,000
-10.58%
|
$120,000
$8.5 P/Share
|
Nov 20
2024
|
Nitin Kaushal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+9.56%
|
$30,000
$2.5 P/Share
|
Nov 19
2024
|
Nitin Kaushal Director |
SELL
Open market or private sale
|
Direct |
15,000
-10.58%
|
$120,000
$8.56 P/Share
|
Nov 19
2024
|
Nitin Kaushal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+9.56%
|
$30,000
$2.5 P/Share
|
Nov 13
2024
|
Nitin Kaushal Director |
SELL
Open market or private sale
|
Direct |
30,000
-19.13%
|
$270,000
$9.48 P/Share
|
Nov 13
2024
|
Nitin Kaushal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+16.06%
|
$60,000
$2.5 P/Share
|
Nov 13
2024
|
Randy E. Dobbs Director |
SELL
Open market or private sale
|
Direct |
36,261
-25.19%
|
$326,349
$9.28 P/Share
|
Nov 13
2024
|
Randy E. Dobbs Director |
BUY
Exercise of conversion of derivative security
|
Direct |
36,261
+20.12%
|
$36,261
$1.81 P/Share
|
Nov 11
2024
|
Nitin Kaushal Director |
SELL
Open market or private sale
|
Direct |
30,000
-19.13%
|
$270,000
$9.56 P/Share
|
Nov 11
2024
|
Nitin Kaushal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+16.06%
|
$60,000
$2.5 P/Share
|
Aug 25
2024
|
Bruce D Greenstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,719
+12.27%
|
-
|
Aug 25
2024
|
Nitin Kaushal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,719
+7.79%
|
-
|
Aug 25
2024
|
William Frazier Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
876
-1.28%
|
$6,132
$7.39 P/Share
|
Aug 25
2024
|
William Frazier Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,594
+4.97%
|
-
|
Aug 25
2024
|
Randy E. Dobbs Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,611
+10.48%
|
-
|
Aug 25
2024
|
Timothy Smokoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,719
+10.47%
|
-
|
Last 12 Months Summary
Exercise of conversion of derivative security | 500K shares |
---|---|
Open market or private purchase | 2.82K shares |
Open market or private sale | 156K shares |
---|---|
Payment of exercise price or tax liability | 70.5K shares |
Sale (or disposition) back to the issuer | 85.2K shares |
Bona fide gift | 26K shares |